Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Tests Accessioned in Natera's CLIA Laboratories by Year
Tests Accessioned in Natera's CLIA Laboratories (tests)
Natera Tests Accessioned in Natera's CLIA Laboratories: 3,468,700.00 tests in FY2025, up 15.6% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“During the year ended December 31, 2025, we processed approximately 3,525,500 tests, comprised of approximately 3,468,700 tests accessioned in our laboratories.”
Source: Form 10-K (FY2025) ↗
Tests accessioned directly in Natera's San Carlos, CA and Austin, TX CLIA-certified laboratories (excludes tests processed via the Constellation cloud software platform).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Tests Accessioned in Natera's CLIA Laboratories (tests) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,468,700.00 | +15.6% | Form 10-K (FY2025) ↗ |
| FY2024 | Dec 31, 2024 | 3,001,900.00 | +23.7% | Form 10-K (FY2025) ↗ |
| FY2023 | Dec 31, 2023 | 2,426,500.00 | +21.1% | Form 10-K (FY2025) ↗ |
| FY2022 | Dec 31, 2022 | 2,004,000.00 | +32.4% | Form 10-K (FY2024) ↗ |
| FY2021 | Dec 31, 2021 | 1,513,400.00 | +55.3% | Form 10-K (FY2023) ↗ |
| FY2020 | Dec 31, 2020 | 974,400.00 | +29.3% | Form 10-K (FY2022) ↗ |
| FY2019 | Dec 31, 2019 | 753,800.00 | +20.4% | Form 10-K (FY2019) ↗ |
| FY2018 | Dec 31, 2018 | 625,900.00 | +28.8% | Form 10-K (FY2018) ↗ |
| FY2017 | Dec 31, 2017 | 486,000.00 | – | Form 10-K (FY2017) ↗ |
| FY2015 | Dec 31, 2015 | 310,600.00 | – | Form 10-K (FY2017) ↗ |
Cite this data
StockData. (2026). Natera Tests Accessioned in Natera's CLIA Laboratories, annual FY2015–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/vol-tests-accessioned-lab
See every metric in the Natera KPI table. Data updated Nov 2, 2026.